about
The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.Meta-analysis of the incidence and risks of interstitial lung disease and QTc prolongation in non-small-cell lung cancer patients treated with ALK inhibitors.Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapy
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Alectinib for ALK-positive non-small-cell lung cancer.
@en
type
label
Alectinib for ALK-positive non-small-cell lung cancer.
@en
prefLabel
Alectinib for ALK-positive non-small-cell lung cancer.
@en
P2860
P1476
Alectinib for ALK-positive non-small-cell lung cancer.
@en
P2860
P304
P356
10.1080/17512433.2016.1195262
P407
P577
2016-05-27T00:00:00Z